Clinical Trial at Scripps Paves Way for More Patients to Benefit from Minimally Invasive Heart Valve Procedure
Cardiologist discusses transcatheter aortic valve replacement
![Paul Teirstein, MD, cardiologist, specializes in interventional cardiology.](http://www.scripps.org/sparkle-assets/images/dr._paul_teirstein_in_operating_room_1200x750-556ea1c3781b4b5f43e8a29b4c4e5741.jpg)
Dr. Paul Teirstein, Interventional Cardiology, Scripps Clinic
Cardiologist discusses transcatheter aortic valve replacement
A recent San Diego Union-Tribune article highlighted Scripps Health’s participation in an important clinical trial that paves the way for more people to benefit from a minimally invasive heart valve replacement procedure as an alternative to open-heart surgery.
Paul Teirstein, MD, an interventional cardiologist at Scripps Clinic, discussed the catheter-based procedure, known as transcatheter aortic valve replacement or TAVR, and its expected expansion to healthier, lower-risk patients who, under current guidelines, must undergo heart surgery to get a new valve.
Read the story in The San Diego Union-Tribune: Octogenerarian weightlifter embraces alternative to open heart surgery.
Media Contact
- Keith Darce
- 858-678-7121
- darce.keith@scrippshealth.org
- Follow me: @KeithDarce